Cancer therapy innovation to overcome traditional limitations
DDW’s Megan Thomas interviews Dr Oren Gilad, President and CEO of Aprea Therapeutics, about the company’s targeted therapeutics that overcome the traditional issues associated with chemotherapy such as toxicity and tumour resistance. MT: Can you provide an overview of Aprea Therapeutics’ approach to developing new cancer therapies and how it… Read More